Teshuva, Itay
Hillel, Inbar
Gazit, Eran
Giladi, Nir
Mirelman, Anat
Hausdorff, Jeffrey M. http://orcid.org/0000-0001-7544-5846
Article History
Received: 18 April 2019
Accepted: 14 May 2019
First Online: 22 May 2019
Compliance with ethical standards
:
: IT, EG, and IH report no conflicts of interests. NG reports that he is a consultant for: Neuroderm, Intec Pharma, Teva, Genzyme-Sanofi, Biogen, Lysosomal Therapeutics, Denali, Cellanis, GaitBetter, Vibrant and Sionara; that he holds shares or options in Lysosomal Therapeutics, Cellanis, GaitBetter and Vibrant; that he has received royalties from Lysosomal Therapeutics; that he received honorarium from UCB, Teva, Novartis, Abbvie, Genzyme-Sanofie, Neuroderm, Bial, Shire, MDS; that he have chaired the DSMBs for Teva and Pharma2B; that he is a PI on a Center Grant given by Biogen to TLVMC; that he has submitted a patent application on the use of body-fixed sensors for assessing PD symptoms, the intellectual property rights for which are held by the Tel Aviv Medical Center, and that he received grants from Teva, Biogen, LTI, ISF, EU, NIH, MJFF, Parkinson Foundation, and Pfizer. AM serves as chair of the Michael J Fox Foundation task force on gait. She has submitted a patent application on the use of body-fixed sensors for assessing PD symptoms, the intellectual property rights for which are held by the Tel Aviv Medical Center. JH has or currently serves on the Movement Disorders Society Technology Task Force, on the Michael J Fox Foundation task force on gait, on the board of the International Society for the Measurement of Physical Behavior, and on advisory boards for Sanofi and Biogen. He has submitted a patent application on the use of body-fixed sensors for assessing PD symptoms, the intellectual property rights for which are held by the Tel Aviv Medical Center. He has received grant support from the NIH, the Michael J Fox Foundation for Parkinson’s Research, the EU (H2020), the BSF, the Israeli Science Foundation and the National Multiple Sclerosis Society.